Dendritic cell vaccine - Shanghai Cell Therapy Group
Alternative Names: Super DC VaccineLatest Information Update: 29 Sep 2023
At a glance
- Originator Shanghai Cell Therapy Group
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Solid tumours
Most Recent Events
- 31 Aug 2023 Phase-I clinical trials in Solid tumours (Adjuvant therapy) in China (Parenteral) (NCT06015269)